In yesterday’s Wall Street session, Zomedica Corp (AMEX:ZOM) shares traded at $0.12, unchanged from the previous session.
ZOM stock price is now -4.30% away from the 50-day moving average and -13.55% away from the 200-day moving average. The market capitalization of the company currently stands at $117.59M.
With the price target of $6, Dawson James recently initiated with Buy rating for Zomedica Corp (AMEX: ZOM).
In other news, Blair Anthony K, COO bought 150,000 shares of the company’s stock on Nov 08 ’24. The stock was bought for $18,450 at an average price of $0.12. Upon completion of the transaction, the COO now directly owns 400,000 shares in the company, valued at $48000.0. An SEC document containing details of the transaction can be found on the SEC’s website. On Nov 11 ’24, Director POWERS JOHNNY D bought 100,000 shares of the business’s stock. A total of $12,100 was incurred on buying the stock at an average price of $0.12. This leaves the insider owning 2,425,000 shares of the company worth $0.29 million. A total of 1.76% of the company’s stock is owned by insiders.
During the past 12 months, Zomedica Corp has had a low of $0.12 and a high of $0.23. As of last week, the company has a debt-to-equity ratio of 0.01, a current ratio of 10.82, and a quick ratio of 10.15. The fifty day moving average price for ZOM is $0.12548 and a two-hundred day moving average price translates $0.13891 for the stock.
The latest earnings results from Zomedica Corp (AMEX: ZOM) was released for 2024-06-30. The net profit margin was -232.70% and return on equity was -26.82% for ZOM. The company reported revenue of $7.0 million for the quarter, compared to $6.35 million a year earlier. Comparatively to last year’s same quarter, the company’s quarterly revenue rose 10.24 percent.
